Table 1.

Effect of fucoidan treatment on blood cell counts

WBC (per μL)Neutrophils
(per μL)
Lymphocytes (per μL)Monocytes (per μL)Eosinophils (per μL)Platelets (×103/μL)
WT PBS 3 540 ± 256 1 022 ± 184 2 374 ± 218 63 ± 12 74 ± 17 920 ± 47 
WT FUC 8 020 ± 1094* 3 078 ± 617* 4 816 ± 567* 65 ± 30 101 ± 71 533 ± 132* 
E−/− PBS 3 120 ± 503 720 ± 144 2 328 ± 398 45 ± 15 34 ± 17 1 019 ± 26 
E−/− FUC 23 333 ± 1 466* 9 373 ± 901* 13 695 ± 1 196* 230 ± 86* 33 ± 33 558 ± 44* 
P/E−/− PBS 9 125 ± 1 916 5 248 ± 1 239 3 423 ± 891 132 ± 50 71 ± 28 966 ± 66 
P/E−/− FUC 26 500 ± 5 804* 13 140 ± 4 870 12 355 ± 1 827* 704 ± 207* 177 ± 106 561 ± 66* 
P/E−/− (spl) PBS 23 016 ± 5 258 11 722 ± 2 692 12 353 ± 2 830 376 ± 55 244 ± 211 1312 ± 81 
P/E−/− (spl) FUC 40 550 ± 8 584 22 119 ± 4 684 19 065 ± 3 417 485 ± 191 216 ± 137 954 ± 160 
WBC (per μL)Neutrophils
(per μL)
Lymphocytes (per μL)Monocytes (per μL)Eosinophils (per μL)Platelets (×103/μL)
WT PBS 3 540 ± 256 1 022 ± 184 2 374 ± 218 63 ± 12 74 ± 17 920 ± 47 
WT FUC 8 020 ± 1094* 3 078 ± 617* 4 816 ± 567* 65 ± 30 101 ± 71 533 ± 132* 
E−/− PBS 3 120 ± 503 720 ± 144 2 328 ± 398 45 ± 15 34 ± 17 1 019 ± 26 
E−/− FUC 23 333 ± 1 466* 9 373 ± 901* 13 695 ± 1 196* 230 ± 86* 33 ± 33 558 ± 44* 
P/E−/− PBS 9 125 ± 1 916 5 248 ± 1 239 3 423 ± 891 132 ± 50 71 ± 28 966 ± 66 
P/E−/− FUC 26 500 ± 5 804* 13 140 ± 4 870 12 355 ± 1 827* 704 ± 207* 177 ± 106 561 ± 66* 
P/E−/− (spl) PBS 23 016 ± 5 258 11 722 ± 2 692 12 353 ± 2 830 376 ± 55 244 ± 211 1312 ± 81 
P/E−/− (spl) FUC 40 550 ± 8 584 22 119 ± 4 684 19 065 ± 3 417 485 ± 191 216 ± 137 954 ± 160 

Mice were treated with 2 doses of fucoidan (FUC; 25 mg/kg) or vehicle (phosphate-buffered saline [PBS]) over 6 hours. Leukocyte and platelet counts were assessed using an automated cell counter and leukocyte subsets were determined using Wright-stained smears.

WT, wild-type; E−/−, E-selectin-deficient; P/E−/−, P- and E-selectin-deficient; spl, splenectomized.

*

P < .05 compared with PBS, n = 3-10.

or Create an Account

Close Modal
Close Modal